OTC · Health care

Medicure Inc (MCUJF)

Medicure Inc reported revenue of CA$21.9M in fiscal 2024, up 1.0% from a year earlier. It posted a net loss of CA$1M. At December 31, 2024 it held CA$7.2M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on April 24, 2026.

Watch MCUJF in 60 seconds

Price

$1.95

+2.63% on the day · September 28, 2026

52-week range $0.67 to $1.95

Revenue (FY2024)

CA$21.9M

+1.0% year on year

Net margin

-4.7%

What Medicure Inc does

Medicure Inc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker MCUJF.

Revenue and profit by year

Revenue

Net income

Fiscal years as reported in annual reports. Amounts in CAD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2024	CA$21.9M	n/a	-CA$1M	-CA$0.10	n/a
2023	CA$21.7M	n/a	-CA$922K	-CA$0.09	n/a
2022	CA$23.1M	n/a	CA$1.4M	CA$0.13	n/a
2021	CA$21.7M	n/a	-CA$727K	-CA$0.07	n/a
2020	CA$11.6M	n/a	-CA$6.8M	-CA$0.64	n/a
2019	CA$20.2M	n/a	-CA$19.8M	-CA$1.32	n/a

Full financial statements: income, balance sheet and cash flow

Where MCUJF ranks in Health care

Revenue growth+1.0%

#395 of 529 in Health care · Bottom 25%

Net margin-4.7%

#245 of 541 in Health care · Top 45%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Medicure Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.

August 19, 2026
Foreign issuer update 6-K
August 19, 2026
Foreign issuer update 6-K
May 21, 2026
Foreign issuer update 6-K
May 21, 2026
Foreign issuer update 6-K
May 21, 2026
Foreign issuer update 6-K
April 24, 2026
Foreign issuer update 6-K
April 24, 2026
Annual report (foreign issuer) 20-F · period to December 31, 2025
April 23, 2026
Foreign issuer update 6-K
November 19, 2025
Foreign issuer update 6-K
November 19, 2025
Foreign issuer update 6-K

All filings on SEC EDGAR

Questions about MCUJF

What does Medicure Inc do?

Medicure Inc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker MCUJF.

Is Medicure Inc profitable?

No. In fiscal 2024 it reported a net loss of CA$1M on revenue of CA$21.9M.

How much revenue does Medicure Inc make?

In fiscal 2024 Medicure Inc reported revenue of CA$21.9M. That is 1.0% more than a year earlier.

When did Medicure Inc last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on April 24, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from August 19, 2026.

Similar companies

TAK

Takeda Pharmaceutical Co Ltd

Compare MCUJF with

Compare MCUJF with any company

Follow MCUJF

Get an email when Medicure Inc files with the SEC: results, executive changes, material agreements and annual reports.

Follow MCUJF: get an email when it files

Where the numbers come from

Financial figures are the values Medicure Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.